Diagnostic performance of actigraphy in Alzheimer's disease using a machine learning classifier - a cross-sectional memory clinic study.

IF 7.9 1区 医学 Q1 CLINICAL NEUROLOGY
Mathias Holsey Gramkow, Andreas Brink-Kjær, Frederikke Kragh Clemmensen, Nikolai Sulkjær Sjælland, Gunhild Waldemar, Poul Jennum, Steen Gregers Hasselbalch, Kristian Steen Frederiksen
{"title":"Diagnostic performance of actigraphy in Alzheimer's disease using a machine learning classifier - a cross-sectional memory clinic study.","authors":"Mathias Holsey Gramkow, Andreas Brink-Kjær, Frederikke Kragh Clemmensen, Nikolai Sulkjær Sjælland, Gunhild Waldemar, Poul Jennum, Steen Gregers Hasselbalch, Kristian Steen Frederiksen","doi":"10.1186/s13195-025-01751-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Movement patterns, activity levels and circadian rhythm are altered in Alzheimer's disease (AD) and can be assessed by actigraphy using wearable sensors. We aimed to determine the diagnostic performance of actigraphy in AD in a memory clinic population by using a machine-learning classifier.</p><p><strong>Methods: </strong>In our single-center cross-sectional study, 70 patients with AD (MCI-moderate dementia), dementia with Lewy bodies (DLB) (N = 29) and cerebrovascular disease (CVD) (N = 23), and 48 elderly healthy controls were included. Participants underwent actigraphy at home using two body-worn sensors (SENS Motion<sup>®</sup>) for 1 week. We derived movement patterns (walking, running, resting, etc.) from raw accelerometry data using a proprietary algorithm. By evaluating the movement patterns during day and nighttime, we calculated 510 activity-related features, including robustness and fragmentation of the circadian rhythm. These features were used to train a machine learning (ML) classifier using logistic regression. We evaluated the performance of our classifier by assessing the accuracy and precision of predictions.</p><p><strong>Results: </strong>We found that movement patterns as well as the robustness and fragmentation of the circadian rhythm differed significantly between groups. During the daytime, patients with AD performed less moderate activity and walked less than the healthy group. While we achieved a modest accuracy of 68.8% for differentiating AD and healthy, the performance was highest (accuracy: 80-89%; precision: 69-84%) when ML was applied to actigraphy data to differentiate dementia etiologies (AD vs. DLB + AD vs. CVD).</p><p><strong>Conclusion: </strong>Actigraphy accurately identifies different dementia etiologies and could serve as a supplement to diagnostic investigations in patients with suspected AD for differential diagnostic purposes.</p>","PeriodicalId":7516,"journal":{"name":"Alzheimer's Research & Therapy","volume":"17 1","pages":"111"},"PeriodicalIF":7.9000,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's Research & Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13195-025-01751-5","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Movement patterns, activity levels and circadian rhythm are altered in Alzheimer's disease (AD) and can be assessed by actigraphy using wearable sensors. We aimed to determine the diagnostic performance of actigraphy in AD in a memory clinic population by using a machine-learning classifier.

Methods: In our single-center cross-sectional study, 70 patients with AD (MCI-moderate dementia), dementia with Lewy bodies (DLB) (N = 29) and cerebrovascular disease (CVD) (N = 23), and 48 elderly healthy controls were included. Participants underwent actigraphy at home using two body-worn sensors (SENS Motion®) for 1 week. We derived movement patterns (walking, running, resting, etc.) from raw accelerometry data using a proprietary algorithm. By evaluating the movement patterns during day and nighttime, we calculated 510 activity-related features, including robustness and fragmentation of the circadian rhythm. These features were used to train a machine learning (ML) classifier using logistic regression. We evaluated the performance of our classifier by assessing the accuracy and precision of predictions.

Results: We found that movement patterns as well as the robustness and fragmentation of the circadian rhythm differed significantly between groups. During the daytime, patients with AD performed less moderate activity and walked less than the healthy group. While we achieved a modest accuracy of 68.8% for differentiating AD and healthy, the performance was highest (accuracy: 80-89%; precision: 69-84%) when ML was applied to actigraphy data to differentiate dementia etiologies (AD vs. DLB + AD vs. CVD).

Conclusion: Actigraphy accurately identifies different dementia etiologies and could serve as a supplement to diagnostic investigations in patients with suspected AD for differential diagnostic purposes.

使用机器学习分类器的活动图在阿尔茨海默病中的诊断性能-一项横断面记忆临床研究。
背景:阿尔茨海默病(AD)患者的运动模式、活动水平和昼夜节律发生改变,可通过使用可穿戴传感器的活动记录仪进行评估。我们的目的是通过使用机器学习分类器来确定记忆诊所人群中AD的活动图诊断性能。方法:采用单中心横断面研究方法,选取AD (mci -中度痴呆)、伴路易体痴呆(DLB)、脑血管病(CVD)患者70例(N = 29)和老年健康对照48例。参与者在家中使用两个穿戴式传感器(SENS Motion®)进行了为期一周的活动记录。我们使用专有算法从原始加速度测量数据中导出运动模式(步行,跑步,休息等)。通过评估白天和夜间的运动模式,我们计算了510个与活动相关的特征,包括昼夜节律的稳健性和碎片化。这些特征用于使用逻辑回归训练机器学习(ML)分类器。我们通过评估预测的准确性和精度来评估分类器的性能。结果:我们发现运动模式以及昼夜节律的稳健性和碎片性在两组之间存在显著差异。在白天,AD患者比健康组进行更少的中度活动和步行。虽然我们在区分AD和健康方面达到了68.8%的适度准确率,但性能最高(准确率:80-89%;当ML应用于活动图数据来区分痴呆病因(AD vs. DLB + AD vs. CVD)时,精度:69-84%)。结论:活动描记能准确识别不同的痴呆病因,可作为疑似AD患者诊断调查的补充,用于鉴别诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Alzheimer's Research & Therapy
Alzheimer's Research & Therapy 医学-神经病学
CiteScore
13.10
自引率
3.30%
发文量
172
审稿时长
>12 weeks
期刊介绍: Alzheimer's Research & Therapy is an international peer-reviewed journal that focuses on translational research into Alzheimer's disease and other neurodegenerative diseases. It publishes open-access basic research, clinical trials, drug discovery and development studies, and epidemiologic studies. The journal also includes reviews, viewpoints, commentaries, debates, and reports. All articles published in Alzheimer's Research & Therapy are included in several reputable databases such as CAS, Current contents, DOAJ, Embase, Journal Citation Reports/Science Edition, MEDLINE, PubMed, PubMed Central, Science Citation Index Expanded (Web of Science) and Scopus.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信